null

Blog

YK-11

YK-11

Sep 2nd 2019

YK-11 is a synthetic SARM that is a gene-selective partial agonist of the androgen receptor. It was first studied in Japan in 2011 by researcher Yuichiro Kanno. YK-11 accelerates the translocation of … read more
SR9009

SR9009

Jul 25th 2019

SR9009 is not a SARM but rather a potent non-addictive Nootropic in the REV-ERB agonist category. REV-ERB proteins regulate the body's core clock and circadian rythm [1], they alter the expression of … read more
RAD-140

RAD-140

Jun 13th 2019

RAD-140 is a SARM developed by Radius Health, Inc. for treatment of conditions like muscle wasting and breast cancer [1]. It exerts anabolic activity in muscle and connective tissue with little effect … read more
S4

S4

Apr 21st 2019

S4, also known as Andarine, was developed by GTX, inc for the treatment of muscle wasting, osteoporosis, and benign prostatic hypertrophy [1]. In a rat model, 1.6mg/kg bodyweight has been shown to sig … read more
LGD-4033

LGD-4033

Apr 14th 2019

LGD-4033 is a 3rd generation non-steroidal oral SARM with a high affinity for the androgen receptor (Ki of ~1 nM). It is currently the second most popular SARM on the market. Unlike testosterone which … read more